≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_LARYNX_EXALLC for full statistics.

Malignant neoplasm of larynx

DOID Endpoint Browser

C3_LARYNX

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C32
  • Cause of death: ICD-9 — 161
  • Cause of death: ICD-8 — 161
  • Cancer registry: Topography ICD-O-3 — C32
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

573

4. Check minimum number of events

None

573

5. Include endpoints

None

573

6. Filter based on genotype QC (FinnGen only)

573

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of larynx based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 573 70 503
Unadjusted period prevalence (%) 0.20 0.02 0.22
Median age at first event (years) 66.94 63.31 67.44

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
529
Matched controls
5289
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
2993.5
323.0
371
*
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
+∞
258.1
226
*
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
+∞
228.1
202
*
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
495.0
225.6
210
7
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
217.9
215.5
211
16
DQA10
NOMESCO Finland
Biopsy of larynx
491.9
202.7
190
6
UDQ22
NOMESCO Finland
Microlaryngoscopy
246.9
159.7
157
9
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
184.2
145.9
147
11
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
811.1
132.6
125
*
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
695.7
116.8
111
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
53.9
112.9
134
33
UJC01
NOMESCO Finland
Scopy of lower throat
83.8
111.5
123
19
C32.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of larynx
587.6
101.1
97
*
DQB30
NOMESCO Finland
Laryngectomy
1107.9
97.2
92
*
ZXC10
NOMESCO Finland
Use of laser
42.1
92.9
116
35
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
1050.0
92.7
88
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
16.3
91.6
156
132
WF002
NOMESCO Finland
Radical radiotherapy
14.6
90.8
163
156
JDB10
NOMESCO Finland
Percutaneous gastrostomy
38.9
89.7
114
37
GBB00
NOMESCO Finland
Tracheostomy
55.3
87.3
103
23
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
36.9
83.2
107
36
130
Kela drug reimbursment
Malignant tumour
8.4
74.8
188
326
EP1AE
NOMESCO Finland
Neck ultrasound examination
12.5
60.3
114
114
8070/3-C32.1
ICD-O-3
Squamous cell carcinoma, NOS, of supraglottis
+∞
57.3
54
*
DQB70
NOMESCO Finland
Total excision of vocal cord
572.3
53.5
52
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
46.0
53.3
65
16
J37.0
ICD-10 Finland
Chronic laryngitis
19.6
53.2
82
49
J38.3
ICD-10 Finland
Other diseases of vocal cords
50.9
52.7
63
14
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
39.5
52.4
66
19
UDH02
NOMESCO Finland
Rhinopharyngoscopy
9.4
49.3
108
140
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
49.3
240
848
1420
FHL
Laryngomicroscopy
34.9
48.0
62
20
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
112.6
47.7
51
5
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
14.8
40.4
69
53
GBB13
NOMESCO Finland
Revision of tracheostomy
+∞
40.1
38
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
68.3
38.7
44
7
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.2
38.5
135
328
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
7.5
37.0
93
147
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
36.7
36.9
47
14
1610A
ICD-9 Finland
Malignant neoplasm of larynx, Glottis
+∞
36.9
35
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
12.2
36.1
67
62
R49.0
ICD-10 Finland
Dysphonia
21.6
36.1
53
27
UDQ02
NOMESCO Finland
Direct laryngoscopy
30.2
35.3
47
17
R4190
NOMESCO Finland
Nutritional therapy
14.6
35.1
60
46
UJC02
NOMESCO Finland
Rigid oesophagoscopy
27.2
32.9
45
18
A07AA02
ATC
nystatin; oral
6.5
31.9
88
157
ZXE00
NOMESCO Finland
One hour or less
3.0
31.2
261
1282
EBA15
NOMESCO Finland
Extraction of large number of teeth
8.2
31.0
72
100
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.0
30.9
145
460
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.2
30.3
70
96
N02AA05
ATC
oxycodone; systemic
3.6
30.0
162
576
A03FA01
ATC
metoclopramide; systemic, rectal
3.5
29.2
162
586
D02.0
ICD-10 Finland
Carcinoma in situ: Larynx
307.8
29.1
29
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.8
29.0
87
172
XX3DW
NOMESCO Finland
Time consuming IT work
4.8
28.6
105
261
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
45.2
28.1
34
8
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
32.9
26.2
34
11
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
26.6
25.6
35
14
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
5.1
25.4
86
195
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.8
25.0
226
1122
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
24.5
248
1314
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.8
24.2
63
103
WX734
NOMESCO Finland
JET-ventilation
130.8
23.8
25
*
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
29.8
23.4
31
11
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
26.1
23.3
32
13
C32.2
ICD-10 Finland
Malignant neoplasm: Subglottis
+∞
23.1
22
*
GBB96
NOMESCO Finland
Other tracheostomy procedure
239.8
22.8
23
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.9
22.6
78
180
GB3AV
NOMESCO Finland
NA
+∞
22.0
21
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.5
22.0
84
215
ZX070
NOMESCO Finland
Intensity modified radiotherapy
10.5
21.5
42
43
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
52.3
21.3
25
5
WX402
NOMESCO Finland
General anaesthesia
3.4
21.2
114
391
C32
ICD-10 Finland
Malignant neoplasm of larynx
218.1
20.7
21
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
34.1
20.4
26
8
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
50.1
20.3
24
5
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
20.2
193
959
WF003
NOMESCO Finland
Adjuvant radiotherapy
8.6
20.1
44
55
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
24.5
20.1
28
12
UJC12
NOMESCO Finland
Flexible oesophagoscopy
21.8
20.1
29
14
R13
ICD-10 Finland
Dysphagia
4.4
19.6
75
192
GD1AD
NOMESCO Finland
Thorax CT examination
5.8
18.9
55
104
UGB02
NOMESCO Finland
Tracheoscopy
72.5
18.8
21
*
TGB20
NOMESCO Finland
Tracheostomy tube replacement
103.7
18.7
20
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
17.9
221
1240
R49.08
ICD-10 Finland
Other specified dysphonia
10.6
17.7
34
34
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
11.7
16.9
31
28
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
65.5
16.8
19
*
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
14.0
16.6
28
21
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.3
16.2
62
158
ZXB10
NOMESCO Finland
Medial
16.3
15.8
25
16
H02AB02
ATC
dexamethasone; systemic
3.4
15.7
79
256
GBA00
NOMESCO Finland
Tracheotomy
87.7
15.6
17
*
C13.9
ICD-10 Finland
Malignant neoplasm: Hypopharynx, unspecified
58.4
14.9
17
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
6.6
14.9
38
61
R23
ICPC
Voice symptom/complaint
12.4
14.7
26
22
C14.1
ICD-10 Finland
Malignant neoplasm of laryngopharynx unspecified
+∞
14.6
14
*
K05.31
ICD-10 Finland
Periodontitis pronounced
3.2
14.3
79
272
EBA10
NOMESCO Finland
Surgical removal of tooth
3.7
13.9
63
187
TJD20
NOMESCO Finland
Change of gastrostomy tube
24.5
13.9
19
8
1611A
ICD-9 Finland
Malignant neoplasm of larynx, Supraglottis
+∞
13.6
13
*
4504
FHL
Laryngectomy
+∞
13.6
13
*
N07BA03
ATC
varenicline; oral
5.7
13.6
39
73
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
13.3
13.5
23
18
WZC30
NOMESCO Finland
Teaching
2.9
13.5
89
347
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.0
13.5
43
91
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
21.8
13.4
19
9
R85
ICPC
Malignant neopl respiratory other
71.6
12.6
14
*
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
71.6
12.6
14
*
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
17.9
12.6
19
11
DQB20
NOMESCO Finland
Partial excision of larynx
+∞
12.5
12
*
DQW99
NOMESCO Finland
Other operation on larynx
132.9
12.5
13
*
H03AA01
ATC
levothyroxine sodium; systemic
2.5
12.3
105
476
A02BC05
ATC
esomeprazole; systemic
2.0
12.1
210
1309
A04AA02
ATC
granisetron; systemic, transdermal
4.0
12.1
49
132
R4130
NOMESCO Finland
Speech therapy
6.4
12.0
31
51
UGC02
NOMESCO Finland
Rigid bronchoscopy
47.8
11.9
14
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
7.6
11.9
27
37
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
11.8
261
1778
GD6AD
NOMESCO Finland
CT of chest and neck
30.8
11.7
15
5
C32.3
ICD-10 Finland
Malignant neoplasm: Laryngeal cartilage
+∞
11.5
11
*
J95.0
ICD-10 Finland
Tracheostomy malfunction
122.5
11.5
12
*
R49.09
ICD-10 Finland
Unspecified dysphonia
12.2
11.4
20
17
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.9
11.4
73
278
Z50.5
ICD-10 Finland
Speech therapy
9.9
11.3
22
23
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
13.1
11.2
19
15
R21
ICPC
Throat symptom/complaint
2.8
11.1
73
283
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
44.3
11.0
13
*
WX002
NOMESCO Finland
Sedation and analgesia
2.2
10.7
119
610
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
12.4
10.4
18
15
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
10.2
153
887
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
6.0
9.5
25
43
C13.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of hypopharynx
30.6
9.4
12
*
SPAT1064
SPAT
Management of tracheostomy stoma
+∞
9.4
9
*
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
+∞
9.4
9
*
R07.0
ICD-10 Finland
Pain in throat
4.4
9.3
33
79
Z3226
NOMESCO Finland
Physiotherapist
2.2
9.2
103
526
A04AA01
ATC
ondansetron; systemic, rectal
3.3
9.1
45
144
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.0
9.1
53
191
Z43.0
ICD-10 Finland
Attention to tracheostomy
37.3
9.0
11
*
A04AD12
ATC
aprepitant; systemic
7.8
8.7
19
25
1340
FHL
Hypopharyngoscopy
50.8
8.7
10
*
EB1WA
NOMESCO Finland
NA
16.6
8.6
13
8
Z2221
NOMESCO Finland
Medical doctor
1.9
8.4
138
824
Z93.0
ICD-10 Finland
Tracheostomy status
+∞
8.3
8
*
4509
FHL
Other measure in this category
+∞
8.3
8
*
J02AC01
ATC
fluconazole; systemic
2.0
8.3
126
727
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
14.8
8.2
13
9
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.0
8.2
110
606
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
6.2
8.2
21
35
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
11.9
8.1
14
12
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
17.5
8.1
12
7
ENA10
NOMESCO Finland
Biopsy of pharynx
33.9
8.1
10
*
1320
FHL
Esophagoscopy
33.9
8.1
10
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
8.0
165
1058
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.1
8.0
24
49
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
15.3
7.7
12
8
Z51.5
ICD-10 Finland
Palliative care
2.7
7.7
52
205
RL210
NOMESCO Finland
NA
25.4
7.6
10
*
5802
FHL
Tracheostomy or coniostomy
81.1
7.4
8
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.6
7.3
24
54
N05BA04
ATC
oxazepam; oral
1.9
7.3
117
685
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
11.1
7.3
13
12
4503
FHL
Partial laryngeal removal
+∞
7.3
7
*
16101
ICD-8 Finland
Malignant neoplasm of larynx, Glottis, true vocal cord
+∞
7.3
7
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.1
7.3
39
134
1430
FHL
Laryngoscopy (direct)
30.4
7.2
9
*
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
30.4
7.2
9
*
ZXD20
NOMESCO Finland
Day surgery
2.3
7.1
66
309
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
3.2
7.1
35
113
K08.3
ICD-10 Finland
Retained dental root
2.7
7.1
48
189
ZXA00
NOMESCO Finland
Right side
1.8
6.9
149
964
A06AD11
ATC
lactulose; oral
1.9
6.8
110
648
WX400
NOMESCO Finland
Inhalation anesthesy
4.0
6.8
25
64
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.9
6.7
114
682
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.6
6.7
28
80
RD210
NOMESCO Finland
NA
6.3
6.5
16
26
Z2446
NOMESCO Finland
Social worker
2.8
6.4
39
146
WX707
NOMESCO Finland
Fiberoscopic intubation
14.5
6.4
10
7
R49.01
ICD-10 Finland
Functional dysphonia
4.5
6.4
21
48
C10.0
ICD-10 Finland
Malignant neoplasm: Vallecula
+∞
6.3
6
*
ENB30
NOMESCO Finland
Laryngopharyngectomy
+∞
6.3
6
*
GBB18
NOMESCO Finland
Closure of tracheostomy
+∞
6.3
6
*
RD160
NOMESCO Finland
NA
27.0
6.2
8
*
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
27.0
6.2
8
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.3
6.1
29
92
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.9
6.1
35
125
SCA03
NOMESCO Finland
Preventive oral health care, extensive
4.1
6.1
22
56

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012095) Magnesium [Moles/volume] in Serum or Plasma
196
735
3.53
41.94
6.2
3.5
mmol/l
0.8
0.8
7.63
190
686
(40768804) Tissue Pathology biopsy report
291
1534
2.82
32.64
3.5
2.3
—
—
—
0
0
(4035726)
113
376
3.50
28.12
1.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
120
526
2.62
17.78
2.1
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
38
86
4.66
15.89
1.2
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
222
1405
1.95
12.76
4.5
3.5
mmol/l
2.3
2.3
0.60
200
1205
(3003458) Phosphate [Moles/volume] in Serum or Plasma
121
618
2.21
12.42
5.8
6.1
mmol/l
1.0
1.0
0.41
111
572
(3024561) Albumin [Mass/volume] in Serum or Plasma
279
1940
1.85
11.73
5.3
5.2
g/l
32.8
34.4
3.66
266
1803
(3044640) Blood type and Crossmatch panel - Blood
215
1388
1.88
11.34
2.8
2.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
74
329
2.43
10.39
1.3
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
307
2265
1.77
10.04
9.5
9.1
e9/l
4.8
4.4
1.51
277
1975
(40758558) Short blood count panel - Blood
161
982
1.89
9.91
7.2
6.7
—
—
—
0
0
(3002256) Pathology report gross observation
105
555
2.09
9.72
1.4
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
123
704
1.95
9.09
1.9
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
266
1929
1.71
8.88
4.4
4.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
166
1055
1.81
8.82
2.7
2.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
168
1077
1.79
8.65
4.9
4.2
%
86.2
81.6
1.37
163
1053
(42870588) Differential panel, method unspecified - Blood
204
1388
1.73
8.51
4.4
5.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
130
2.89
7.63
1.7
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
86
473
1.96
7.04
1.6
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
260
1962
1.60
6.87
4.8
5.5
e9/l
0.7
0.6
2.08
218
1652
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
215
2814
0.62
6.82
4.2
5.4
ug/l
2.5
3.4
1.13
185
2476
(3006504) Eosinophils/100 leukocytes in Blood
249
1863
1.60
6.81
5.1
5.6
%
2.6
2.9
1.24
234
1724
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
291
2259
1.59
6.79
7.3
6.8
umol/l
11.3
13.0
1.68
285
2139
(3019069) Monocytes/100 leukocytes in Blood
250
1874
1.59
6.77
5.2
5.9
%
9.5
9.2
0.68
235
1738
(3006315) Basophils [#/volume] in Blood
260
1972
1.58
6.66
4.8
5.5
e9/l
0.0
0.0
0.10
217
1676
(3018010) Neutrophils/100 leukocytes in Blood
248
1864
1.58
6.59
4.9
5.6
%
63.8
59.0
6.77
230
1730
(3002030) Lymphocytes/100 leukocytes in Blood
252
1904
1.58
6.53
5.1
5.8
%
20.2
25.2
9.88
235
1752
(3019198) Lymphocytes [#/volume] in Blood
262
2002
1.57
6.43
4.8
5.6
e9/l
1.6
2.0
0.82
224
1732
(3022096) Basophils/100 leukocytes in Blood
242
1817
1.57
6.41
5.1
5.6
%
0.6
0.6
0.44
228
1687
(3013115) Eosinophils [#/volume] in Blood
264
2027
1.56
6.31
4.9
5.6
e9/l
0.2
0.2
0.26
230
1757
(3051611) Lipemic interference index of Serum or Plasma
18
49
3.76
5.96
3.3
3.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
313
3720
0.65
5.91
4.0
4.8
mmol/l
1.3
1.3
0.02
271
3334
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
319
3754
0.66
5.48
4.1
4.8
mmol/l
4.4
4.3
0.86
286
3401
(3051651) Icteric interference index of Serum or Plasma
13
30
4.41
5.32
3.5
3.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
306
3609
0.67
5.09
3.8
4.3
mmol/l
1.3
1.3
0.34
266
3222
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
22
77
2.93
4.98
1.1
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
43
211
2.12
4.82
2.4
3.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
124
845
1.60
4.77
2.0
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
251
1991
1.46
4.71
9.4
6.5
mmol/l
1.2
1.2
3.80
232
1781
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
173
2256
0.67
4.69
4.0
4.6
%
22.7
21.4
0.48
67
1167
(1761868) Lipid panel - Serum or Plasma
74
1170
0.58
4.67
2.8
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
103
1493
0.62
4.56
3.2
4.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
93
598
1.66
4.50
1.8
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
196
1499
1.47
4.37
5.6
4.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
21
78
2.76
4.30
1.4
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
63
369
1.79
4.25
2.1
1.7
%
2.0
1.7
1.40
43
297
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
81
510
1.69
4.24
2.3
3.0
umol/l
6.7
10.0
1.60
74
465
(3000991) Gas panel - Venous blood
68
409
1.75
4.20
13.7
9.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
64
379
1.78
4.16
2.3
2.4
u/l
36.4
34.0
0.12
51
319
(3023419) Bacteria identified in Sputum by Culture
20
74
2.76
4.13
2.0
2.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
37
3.57
4.07
1.2
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
265
2165
1.42
4.06
11.0
7.3
mmol/l
1.2
1.2
2.71
222
1793
(3003396) Base excess in Arterial blood by calculation
92
607
1.61
4.02
11.5
7.9
mmol/l
2.4
1.3
1.23
76
475
(3021447) Carbon dioxide [Partial pressure] in Venous blood
72
448
1.69
3.94
3.1
4.2
kpa
6.0
5.8
0.77
67
433
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
339
3849
0.71
3.88
4.5
5.4
mmol/l
2.6
2.5
0.44
302
3449
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
22
485
0.43
3.84
1.1
1.3
u/ml
1.4
12.6
—
7
175
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
90
598
1.60
3.82
1.9
1.9
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
108
2.37
3.81
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
108
2.37
3.81
1.3
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
91
610
1.58
3.72
11.7
7.8
kpa
11.2
11.6
0.38
86
588
(3002032) Base excess in Venous blood by calculation
71
450
1.66
3.63
3.2
4.2
mmol/l
1.9
1.9
0.04
55
351
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
38
199
1.97
3.62
2.1
2.3
u/ml
0.3
0.3
0.61
16
107
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
29
138
2.16
3.55
1.0
1.2
iu/ml
107.8
111.0
0.02
13
45
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
31
3.60
3.49
1.1
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
134
992
1.46
3.43
1.5
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
150
1918
0.70
3.33
2.8
3.8
estimate
0.0
0.0
0.00
32
363
(3023199) Leukocytes [#/volume] in Pleural fluid
19
77
2.52
3.33
1.3
1.3
e6/l
6958.5
1432.4
0.60
13
49
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
67
1001
0.63
3.26
1.6
1.8
pmol/l
466.5
7011479.9
0.50
55
813
(3045788) Cell count panel - Pleural fluid
16
61
2.67
3.16
1.4
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
75
500
1.58
3.14
4.9
3.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
328
3693
0.74
3.14
5.3
6.7
mmol/mol
39.6
41.3
3.18
297
3347
(3021601) Nitrite [Presence] in Urine by Test strip
150
1902
0.71
3.12
3.7
5.1
estimate
0.0
0.0
0.00
31
371
(3012441) Differential panel - Pleural fluid
17
68
2.55
3.07
1.5
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
48
287
1.73
3.06
1.4
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
10
29
3.49
3.06
1.1
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
154
1938
0.72
3.05
2.8
3.8
estimate
0.0
0.0
0.00
31
356
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
117
864
1.45
3.02
3.8
3.5
mmol/l
2.5
2.5
1.85
94
751
(3018418) pH of Serum or Plasma
161
1262
1.38
2.96
5.8
4.4
ph
7.4
7.4
0.06
35
246
(1616796) Gas panel - Central venous blood
23
108
2.18
2.94
5.4
4.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
28
144
1.99
2.85
4.7
3.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
42
248
1.75
2.81
1.6
1.7
g/l
2.0
1.6
1.81
37
213
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
23
3.96
2.78
3.9
4.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
20
4.04
2.57
1.4
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
76
1052
0.68
2.54
3.0
3.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
299
2612
1.30
2.53
7.1
5.3
mmol/l
6.5
6.9
4.08
284
2464
(3028308) Erythrocytes [#/volume] in Pleural fluid
16
69
2.36
2.50
1.2
1.3
e6/l
34534.6
32375.9
—
10
40
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
26
3.50
2.49
1.8
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
26
3.50
2.49
1.8
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
355
3179
1.31
2.47
9.5
8.1
u/l
82.8
82.2
0.08
337
2958
(40768797) Stomach Pathology biopsy report
73
513
1.48
2.43
1.4
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
44
275
1.65
2.43
12.0
10.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
238
2027
1.30
2.41
8.2
11.1
inr
1.2
1.3
1.17
58
546
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
345
3794
0.77
2.35
4.5
5.1
mmol/l
6.0
6.2
1.49
310
3374
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
154
1253
1.31
2.15
3.3
3.4
u/l
32.1
37.9
1.00
143
1192
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
32
513
0.60
2.10
1.1
1.2
iu/ml
12.2
37.4
2.79
12
165
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
56
2.35
2.06
1.5
1.9
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
15
4.03
2.04
2.7
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
163
0.36
2.04
1.0
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
46
305
1.55
2.03
3.1
4.4
ng/l
70.3
99.9
1.41
41
265
(3019150) Specific gravity of Urine by Refractometry
62
851
0.70
1.97
2.8
4.2
kg/l
1.0
1.0
1.22
13
138
(3028707) Methadone [Presence] in Urine by Screen method
5
11
4.57
1.94
1.0
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
53
0.00
1.87
0.0
1.1
—
48.3
—
0
12
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
34
2.67
1.87
1.8
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
134
1622
0.77
1.85
3.1
3.2
ug/l
0.7
0.8
0.64
99
1137
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
78
1014
0.73
1.79
1.4
1.7
mmol/l
1.3
1.3
0.04
64
818
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
294
2634
1.24
1.79
4.4
3.3
pmol/l
14.4
15.0
2.88
271
2303
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
24
139
1.76
1.78
1.8
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
120
1466
0.77
1.77
4.3
4.0
mg/mmol
12.7
9.5
0.35
73
979
(40761535) Cells panel - Urine sediment
23
382
0.59
1.76
4.0
3.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
41
2.46
1.76
1.7
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
13
3.87
1.72
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
48
2.32
1.71
8.9
3.9
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
49
0.00
1.69
0.0
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
42
2.41
1.68
1.1
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
531
0.66
1.67
8.1
9.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
190
0.47
1.64
1.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
249
0.51
1.63
2.6
4.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
162
1891
0.80
1.62
4.3
4.1
ng/l
71.4
51.8
0.31
135
1486
(3027945) Reticulocytes/100 erythrocytes in Blood
80
617
1.34
1.62
2.2
2.4
%
1.7
1.8
0.20
74
559
(3029937) Albumin [Presence] in Urine by Test strip
85
1074
0.76
1.61
3.0
4.0
estimate
0.0
0.0
0.00
25
342
(3010813) Leukocytes [#/volume] in Blood
399
4243
0.80
1.60
36.3
25.8
e9/l
7.3
7.1
0.63
382
4090
(3026361) Erythrocytes [#/volume] in Blood
399
4241
0.81
1.58
36.3
25.8
e12/l
4.2
4.5
10.57
383
4088
(3000963) Hemoglobin [Mass/volume] in Blood
399
4241
0.81
1.58
36.6
25.9
g/l
128.3
135.2
12.69
390
4152
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
158
0.44
1.57
1.3
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
399
4240
0.81
1.57
36.2
25.7
fl
92.6
91.9
2.08
390
4155
(3007461) Platelets [#/volume] in Blood
399
4240
0.81
1.57
36.2
25.8
e9/l
248.5
231.1
4.69
384
4109
(3035941) MCH [Entitic mass]
399
4240
0.81
1.57
36.1
25.7
pg
30.7
30.6
0.67
390
4154
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
46
325
1.45
1.55
3.2
3.1
ml/min/173m2
57.0
61.4
0.31
20
144
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
133
1579
0.79
1.53
2.3
3.2
ng/l
2355.3
2019.6
0.19
114
1382
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
68
517
1.36
1.51
3.1
4.6
ug/l
7.3
44.7
1.52
56
438
(3022313) Gas panel - Capillary blood
39
268
1.49
1.51
4.5
3.7
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
6
21
2.88
1.51
1.3
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
45
0.00
1.50
0.0
1.0
—
1.8
—
0
13
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
386
4103
0.82
1.44
12.9
11.3
u/l
23.6
26.4
3.23
373
3920
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
137
0.43
1.42
1.3
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
46
332
1.42
1.40
1.8
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
109
896
1.27
1.39
4.8
4.1
ng/l
259.4
343.1
0.37
98
776
(3000492) Spirometry study
47
341
1.41
1.39
1.4
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
89
1.82
1.38
1.6
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
121
1.68
1.32
1.5
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
69
1.90
1.29
1.6
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
99
1191
0.80
1.27
2.9
3.0
umol/l
368.7
7976.4
4.87
77
1009
(3012516) Albumin [Mass/volume] in Urine
116
1371
0.81
1.27
3.7
3.3
mg/l
1211.0
302.2
0.57
75
939
(3009343) pH of Capillary blood
49
365
1.37
1.26
5.1
3.5
ph
7.4
7.4
—
5
38
(3037756) Immunofixation for Serum or Plasma
5
117
0.42
1.26
1.6
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
25
2.41
1.24
1.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
36
2.24
1.24
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
8
36
2.24
1.24
1.5
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
36
2.24
1.24
1.1
1.1
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
37
2.18
1.22
1.0
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
189
1.51
1.21
1.7
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
116
980
1.23
1.18
1.6
1.8
nmol/l
1055.8
1154.4
0.53
87
744
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
128
0.46
1.18
1.2
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
8
39
2.07
1.15
1.1
1.4
mu/l
26.6
47.5
—
8
34
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
49
372
1.35
1.14
5.1
3.5
kpa
5.3
5.1
0.88
44
344
(3000475) Leukocytes [#/volume] in Synovial fluid
5
114
0.43
1.13
1.2
1.7
e6/l
9989.0
13051.8
—
5
87
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
30
209
1.46
1.13
2.0
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
165
1450
1.19
1.12
3.2
3.7
e6/l
202.6
138.2
0.21
121
1167
(40768443) Skin Pathology biopsy report
10
182
0.54
1.12
1.3
1.3
—
—
—
0
0
(3013512) EKG study
121
1406
0.82
1.12
5.1
4.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
81
1.75
1.10
3.4
3.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
21
2.39
1.09
1.6
3.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
120
1389
0.83
1.06
3.6
3.2
mmol/l
6.8
7.9
2.68
92
1131
(3039443) Prostate specific Ag panel - Serum or Plasma
6
124
0.48
1.06
2.3
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
12
203
0.58
1.05
1.2
1.3
—
31.0
—
0
14
(3021589) Normoblasts [#/volume] in Blood
195
1749
1.17
1.04
12.8
10.3
e9/l
0.0
0.0
0.95
149
1421
(40761511) CBC panel - Blood by Automated count
379
3990
0.85
1.03
23.5
17.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
396
4154
0.85
1.03
31.0
21.4
mmol/l
4.0
4.0
3.24
385
4036
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
47
1.93
1.02
1.6
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
45
344
1.33
1.02
5.1
3.6
mmol/l
2.5
2.0
0.35
37
260
(1002224) Polysomnography panel
5
108
0.46
1.01
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
365
0.70
1.00
1.3
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
23
2.18
0.98
1.2
2.7
u/l
188.2
204.2
—
5
23
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.0
—
9.0
—
0
10
(3037522) Nuclear Ab [Titer] in Serum
31
420
0.72
0.97
1.3
1.3
titre
240.0
463.7
—
6
91
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.1
—
1.3
—
0
11
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
30
0.00
0.97
0.0
2.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
54
1.87
0.97
3.1
2.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
396
4145
0.86
0.95
30.8
21.3
mmol/l
138.8
139.6
6.49
385
4026
(3044889) 12 lead EKG panel
309
2885
1.15
0.95
4.3
4.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
44
560
0.77
0.92
4.7
4.7
%
32.1
31.8
0.06
32
376
(46235355) HIV 1 and 2 tests - Meaningful Use set
49
387
1.29
0.90
1.3
1.6
—
—
—
0
0
(4094501)
5
104
0.48
0.89
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
181
0.60
0.89
1.3
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
192
0.62
0.87
1.7
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
34
444
0.75
0.86
1.5
2.2
nmol/l
10.9
12.6
0.67
29
389
(3019225) pH of Specimen
54
435
1.27
0.86
7.0
4.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
31
1.95
0.84
1.0
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
34
442
0.75
0.84
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
13
201
0.64
0.82
1.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
32
1.88
0.82
1.0
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.1
—
8.3
—
0
19
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
25
0.00
0.79
0.0
2.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
134
1192
1.16
0.79
2.0
2.1
mg/l
2.7
3.1
1.37
109
1019
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
74
1.63
0.78
3.7
3.3
%
70.4
57.7
2.48
12
74
(3019230) Fractional oxyhemoglobin in Venous blood
13
82
1.60
0.78
2.2
3.0
%
56.5
62.5
0.41
13
82
(3047189) Immunofixation for 24 hour Urine
0
27
0.00
0.77
0.0
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
27
0.00
0.77
0.0
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
23
311
0.73
0.75
1.6
2.3
ug/g
197.1
162.5
0.11
16
260
(3019060) Gas panel - Arterial blood
46
371
1.26
0.74
5.4
4.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.6
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.6
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.6
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.6
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
101
1.50
0.70
2.3
3.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
76
881
0.84
0.70
2.2
3.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
93
1.52
0.70
1.4
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
20
273
0.72
0.70
3.5
3.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
69
1.61
0.69
1.7
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
27
1.86
0.68
1.6
2.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
117
0.59
0.68
1.1
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
263
2792
0.89
0.67
4.0
4.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
136
1229
1.14
0.65
2.9
3.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
121
1.42
0.63
1.6
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
201
1866
1.12
0.62
2.0
2.1
pmol/l
82.1
90.9
2.14
118
1032
(4268621)
5
30
1.67
0.61
2.2
2.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
174
1605
1.12
0.60
3.7
4.1
e6/l
120.2
141.6
0.13
124
1234
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
90
795
1.16
0.60
2.7
3.3
e6/l
1.3
0.8
0.74
45
506
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
42
346
1.23
0.59
1.7
1.7
—
—
—
0
0
(44806420)
0
23
0.00
0.58
0.0
2.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
37
1.63
0.55
1.3
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
55
640
0.84
0.55
1.1
1.2
u/ml
1.4
1.2
0.09
14
163
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
194
1810
1.11
0.54
2.6
2.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
9
61
1.48
0.54
7.0
9.4
mmol/l
6.8
7.2
—
9
53
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
355
3676
0.91
0.50
25.1
16.8
ml/min/173m2
77.6
73.7
2.72
307
3073
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
182
1701
1.10
0.49
3.6
3.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
109
0.64
0.49
1.1
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
46
1.53
0.48
1.3
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
76
677
1.14
0.47
2.5
2.6
%
23.2
22.6
0.11
70
590
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
94
1.39
0.46
1.1
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
146
1355
1.10
0.45
2.9
2.6
u/l
54.3
56.4
0.30
138
1251
(3013707) Erythrocyte sedimentation rate by Westergren method
279
2911
0.92
0.45
3.8
4.1
mm/h
18.6
14.2
3.19
252
2635
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
9
131
0.68
0.43
1.4
1.7
nmol/l
42.8
43.3
—
9
123
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
70
1.44
0.42
4.0
2.8
e9/l
5.3
4.5
—
10
70
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
10.0
—
0
5
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.4
—
0.9
—
0
17
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.1
—
1.0
—
0
9
(3011648) Oxygen content in Venous blood
5
34
1.47
0.40
2.4
1.8
%
8.5
10.9
—
5
34
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
120.2
—
0
12
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
49.8
—
0
10
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
110
1015
1.10
0.39
2.8
2.8
e6/l
4.2
3.5
0.45
97
890
(3005322) IgE [Units/volume] in Serum or Plasma
12
159
0.75
0.39
2.3
1.2
u/ml
390.9
194.1
0.51
12
141
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
80
1.38
0.38
1.7
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
68
1.33
0.37
2.2
4.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
140
1310
1.09
0.37
2.9
3.5
e6/l
0.2
0.6
2.89
99
1026
(3022217) INR in Platelet poor plasma by Coagulation assay
82
748
1.11
0.36
23.6
29.2
inr
1.4
1.5
0.29
12
92
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
71
1.27
0.36
1.1
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
78
0.64
0.36
1.2
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
80
0.62
0.35
1.0
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
117
1.29
0.35
1.7
1.6
ug/g
252.3
243.4
—
10
69
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.7
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.7
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.7
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
97
0.72
0.31
1.3
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
75
1.34
0.30
1.8
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
141
1.21
0.26
1.2
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
77
1.30
0.26
1.1
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
72
0.69
0.26
1.2
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
75
0.66
0.26
1.2
1.2
—
3.6
—
0
11
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
74
1.22
0.25
2.9
3.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
126
0.79
0.24
1.3
3.9
—
—
—
0
0
(3026782) Osmolality of Urine
103
972
1.07
0.24
3.0
3.1
mosm/kgh2o
558.8
587.6
0.73
88
826
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
106
1.23
0.23
1.7
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
190
1.16
0.23
1.6
2.7
g/l
2.9
3.2
0.44
14
149
(3000093) Morphology [Interpretation] in Blood Narrative
5
39
1.28
0.23
2.6
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
244
2369
1.05
0.22
3.6
3.3
u/l
77.4
60.7
0.61
223
2169
(3022621) pH of Urine by Test strip
25
284
0.87
0.22
2.4
2.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
38
419
0.90
0.22
2.2
2.8
g/l
66.2
66.2
0.00
33
380
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
49
450
1.10
0.21
2.5
3.2
ng/l
351.6
246.5
0.45
43
411
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
11
0.00
0.21
0.0
6.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
18.3
—
1691.3
—
0
10
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
37.4
—
0
10
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
13.0
—
995.5
—
0
10
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
6.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
10
0.00
0.21
0.0
9.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
10
0.00
0.21
0.0
3.0
—
13.6
—
0
10
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
10
0.00
0.21
0.0
1.8
—
1.2
—
0
10
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
12
0.00
0.21
0.0
8.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
299
3058
0.95
0.21
31.4
23.5
g/l
331.4
332.7
1.45
294
3031
(3004616) Nuclear Ab [Presence] in Serum
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.5
—
70.1
—
0
13
(3024471) HLA-A [Type]
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
13
0.00
0.21
0.0
2.0
—
95.5
—
0
13
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
13
0.00
0.21
0.0
8.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
59
634
0.92
0.20
1.1
1.3
g/l
3.3
2.9
0.53
33
393
(3028433) Virus identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
18
155
1.17
0.20
5.7
2.7
mmol/l
25.5
25.0
0.14
13
132
(3026008) Bacteria identified in Urine by Culture
117
1223
0.95
0.19
2.7
3.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
90
1.23
0.19
1.7
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
12
143
0.84
0.19
1.4
1.6
—
142.5
—
0
8
(3009542) Hematocrit [Volume Fraction] of Blood
329
3349
0.96
0.18
27.1
19.1
%
38.4
39.0
0.56
228
2083
(3017143) Hepatitis C virus Ab [Presence] in Serum
36
330
1.10
0.17
1.4
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
63
1.11
0.17
1.1
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
85
810
1.06
0.16
2.4
3.1
e6/l
0.8
1.0
0.33
40
515
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
27
245
1.11
0.15
1.4
2.0
ug/l
0.9
1.3
0.28
22
212
(3004588) Protein electrophoresis panel - Serum or Plasma
31
338
0.91
0.15
1.7
2.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
23
255
0.90
0.15
2.1
3.0
e9/l
4.6
3.9
0.46
18
182
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
7
88
0.79
0.14
1.3
1.3
mg/l
765.9
538.2
—
7
79
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
15
170
0.88
0.14
1.7
1.9
u/l
43.4
37.7
0.49
15
147
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
8
98
0.81
0.13
1.8
1.8
pmol/l
229.1
221.3
—
8
89
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
117
0.85
0.13
1.1
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
9
110
0.82
0.13
1.0
1.9
mg/l
11.8
13.6
—
9
98
(3013139) Helicobacter pylori Ag [Presence] in Stool
21
190
1.11
0.13
1.4
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
200
1.10
0.12
1.6
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
200
1.10
0.12
1.6
2.6
g/l
7.8
7.4
0.42
15
152
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
200
1.10
0.12
1.6
2.6
g/l
3.9
3.8
0.21
14
146
(40767503) Oxygen content in Capillary blood by calculation
12
104
1.16
0.12
5.4
2.6
%
14.0
16.0
—
7
55
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
85
818
1.05
0.12
1.6
1.7
mg/l
1.2
1.5
0.72
65
659
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
114
1.14
0.12
1.2
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
157
1608
0.97
0.11
2.7
2.7
ug/l
190.7
184.6
0.09
145
1461
(3023520) Reticulocytes [#/volume] in Blood
44
465
0.94
0.11
3.2
2.4
e9/l
72.2
67.9
0.33
37
372
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
182
1.10
0.11
1.7
2.7
g/l
10.6
10.9
0.12
14
156
(3021901) Oxygen saturation in Capillary blood
12
105
1.15
0.11
6.1
2.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
344
3400
1.03
0.11
5.3
4.1
mu/l
3.2
2.0
4.17
313
3000
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
86
1.17
0.11
1.7
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
131
1343
0.97
0.10
2.2
2.2
u/l
175.5
318.5
1.39
124
1260
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.2
1.9
—
—
—
0
0
(4010399)
30
281
1.07
0.09
1.2
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
117
1140
1.03
0.09
1.6
1.6
nmol/l
18.0
19.5
0.51
103
958
(21494434) Karyotype in Bone marrow
5
47
1.06
0.09
1.0
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
29
309
0.94
0.09
4.2
4.5
%
0.0
0.1
0.78
15
99
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
35
331
1.06
0.09
1.5
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
55
1.09
0.09
1.3
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
204
1.08
0.09
1.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
56
1.07
0.08
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
57
1.05
0.08
1.3
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
57
1.05
0.08
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
58
1.03
0.08
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
58
1.03
0.08
1.3
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
63
0.79
0.08
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
65
1.08
0.08
1.3
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
71
0.84
0.07
1.2
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
73
0.82
0.07
1.2
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
311
3080
1.02
0.07
31.5
21.7
%
14.1
13.9
1.90
306
3009
(40761536) Microorganisms panel - Urine sediment
33
347
0.95
0.07
4.2
4.0
—
—
—
0
0
(3020891) Body temperature
21
196
1.07
0.07
5.0
4.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
85
1.06
0.07
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
90
0.89
0.07
1.1
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
103
0.87
0.06
1.7
2.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
33
315
1.05
0.06
3.8
4.3
%
0.3
0.5
0.46
16
93
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
11
101
1.09
0.04
1.0
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
388
3897
0.99
0.04
27.3
18.0
mg/l
33.2
29.6
1.33
363
3228
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
150
1485
1.01
0.03
1.9
2.1
nmol/l
74.4
76.8
0.38
128
1284
(40760892) CBC W Ordered Manual Differential panel - Blood
79
780
1.01
0.02
3.6
4.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
103
1.07
0.02
1.1
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
47
463
1.02
0.01
2.1
2.7
ug/l
3.3
7.6
4.35
42
402
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
126
0.95
0.00
1.4
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
35
356
0.98
0.00
3.7
4.4
%
0.8
0.8
0.03
17
126
(3021440) Promyelocytes/100 leukocytes in Blood
33
335
0.98
0.00
3.8
4.4
%
0.1
0.1
0.01
16
115
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
137
1.02
0.00
1.3
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
173
0.98
0.00
1.4
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
98
1.02
0.00
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
98
1.02
0.00
1.1
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
237
1.01
0.00
2.2
2.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
99
1.01
0.00
1.1
1.2
—
—
—
0
0
(44806118)
5
56
0.89
0.00
1.2
1.6
—
—
—
0
0
(44790049)
5
56
0.89
0.00
1.2
1.6
—
—
—
0
0
(44790047)
5
56
0.89
0.00
1.2
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
70
1.00
0.00
1.0
1.1
—
—
—
0
0
(44790048)
5
56
0.89
0.00
1.2
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
70
1.00
0.00
3.4
2.4
pg
29.4
33.0
—
7
70
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
69
1.01
0.00
1.4
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
49
1.02
0.00
4.0
2.5
nmol/l
34.6
4.1
—
5
49
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
5
52
0.96
0.00
1.4
1.5
%
50.0
65.2
—
5
40
(3001186) Copper [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
17.7
—
0
6
(3000285) Sodium [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
72
0.97
0.00
1.3
1.3
mmol/l
4.3
3.9
—
7
64
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
1.8
—
1.2
—
0
9
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
52
0.96
0.00
1.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
83
0.96
0.00
1.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
15.5
—
0
7
(3009871) Measles virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
100
1.00
0.00
1.5
2.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
24.1
—
0
6
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
11.3
—
0
6
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
96.5
—
0
6
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
9
0.00
0.00
0.0
3.8
—
8863.6
—
0
9
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
-0.00
0.0
8.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.4
—
61.4
—
0
5
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
5
0.00
-0.00
0.0
1.0
—
8.9
—
0
5
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_LARYNX – Malignant neoplasm of larynx

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).